IL110385A - Melanoma-inhibiting protein - Google Patents
Melanoma-inhibiting proteinInfo
- Publication number
- IL110385A IL110385A IL11038594A IL11038594A IL110385A IL 110385 A IL110385 A IL 110385A IL 11038594 A IL11038594 A IL 11038594A IL 11038594 A IL11038594 A IL 11038594A IL 110385 A IL110385 A IL 110385A
- Authority
- IL
- Israel
- Prior art keywords
- iib
- iia
- protein
- melanoma
- htz
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 230000002401 inhibitory effect Effects 0.000 title abstract 2
- 201000001441 melanoma Diseases 0.000 title abstract 2
- 210000003527 eukaryotic cell Anatomy 0.000 abstract 2
- 108020004414 DNA Proteins 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 108010076504 Protein Sorting Signals Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000010261 cell growth Effects 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 210000001236 prokaryotic cell Anatomy 0.000 abstract 1
- 238000003259 recombinant expression Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL154248A IL154248A (en) | 1993-07-20 | 1994-07-20 | Antibody against melanoma-inhibiting protein |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4324247 | 1993-07-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL110385A0 IL110385A0 (en) | 1994-10-21 |
| IL110385A true IL110385A (en) | 2003-12-10 |
Family
ID=6493222
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11038594A IL110385A (en) | 1993-07-20 | 1994-07-20 | Melanoma-inhibiting protein |
| IL154248A IL154248A (en) | 1993-07-20 | 1994-07-20 | Antibody against melanoma-inhibiting protein |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL154248A IL154248A (en) | 1993-07-20 | 1994-07-20 | Antibody against melanoma-inhibiting protein |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5770366A (es) |
| EP (2) | EP0710248B1 (es) |
| JP (1) | JP3435163B2 (es) |
| CN (1) | CN1056617C (es) |
| AT (1) | ATE185152T1 (es) |
| AU (1) | AU7531294A (es) |
| CA (1) | CA2167693C (es) |
| DE (2) | DE4425481A1 (es) |
| DK (1) | DK0710248T3 (es) |
| ES (1) | ES2139751T3 (es) |
| GR (1) | GR3032212T3 (es) |
| IL (2) | IL110385A (es) |
| WO (1) | WO1995003328A2 (es) |
| ZA (1) | ZA945278B (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19653358A1 (de) * | 1996-12-20 | 1998-06-25 | Boehringer Mannheim Gmbh | Immunoassay zum Nachweis von MIA |
| JP2001509029A (ja) | 1997-01-21 | 2001-07-10 | ヒューマン ジノーム サイエンシーズ，インコーポレイテッド | ヒトタンパク質 |
| USRE39920E1 (en) | 1997-05-30 | 2007-11-13 | Xenomics, Inc. | Methods for detection of nucleic acid sequences in urine |
| US6492144B1 (en) * | 1997-05-30 | 2002-12-10 | Diagen Corporation | Methods for detection of nucleic acid sequences in urine |
| EP0945507A1 (de) * | 1998-03-27 | 1999-09-29 | Boehringer Mannheim Gmbh | Tumorspezifische Expressionskontrollregion und deren Verwendung |
| US20020103360A1 (en) * | 1998-09-01 | 2002-08-01 | Yang Pan | Novel protein related to melanoma-inhibiting protein and uses thereof |
| US20030072767A1 (en) * | 1998-09-30 | 2003-04-17 | Alexander Gaiger | Compositions and methods for WT1 specific immunotherapy |
| EP1025871A1 (en) * | 1999-01-28 | 2000-08-09 | F. Hoffmann-La Roche Ag | Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair |
| US6713293B1 (en) * | 1999-02-08 | 2004-03-30 | Friedrich Grummt | Encapsulated cells containing an amplified expression vector as a drug delivery device |
| KR20020026465A (ko) * | 1999-06-30 | 2002-04-10 | 다케다 야쿠힌 고교 가부시키가이샤 | 신규 폴리펩티드 및 그의 ｄｎａ |
| AU2001232967A1 (en) * | 2000-01-25 | 2001-08-07 | Hyseq, Inc. | Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides |
| EP1133994A1 (en) * | 2000-03-11 | 2001-09-19 | Biognostik Gesellschaft für biomolekulare Diagnostik mbH | A method for reversing the immunosuppressive effects of the Melanoma Inhibitory Activity "MIA" |
| WO2001070253A1 (en) * | 2000-03-23 | 2001-09-27 | Akzo Nobel N.V. | Use of mia in immunotherapy |
| US6613534B2 (en) | 2001-03-20 | 2003-09-02 | Wake Forest University Health Sciences | MAP-2 as a determinant of metastatic potential |
| US20100212037A1 (en) * | 2002-10-16 | 2010-08-19 | Anja Katrin Bosserhoff | Mia-2 protein |
| AU2007277144B2 (en) * | 2006-07-28 | 2012-01-19 | Novartis Ag | Use of melanoma inhibitory activity (MIA) protein as an early indicator for therapeutic response in melanoma |
| ES2660785T3 (es) * | 2007-08-22 | 2018-03-26 | Trovagene, Inc. | Métodos de uso de ARNmi para la detección de la muerte de células in vivo |
| RU2588658C2 (ru) | 2010-04-27 | 2016-07-10 | ЭсСиАйЭл Текнолоджи ГмбХ | Стабильные водные композиции белка mia/cd-rap |
| WO2012028523A2 (en) * | 2010-08-30 | 2012-03-08 | F. Hoffmann-La Roche Ag | Prokaryotic expression construct |
| ITRM20110134A1 (it) * | 2011-03-22 | 2012-09-23 | Matteo Bordignon | Inibitori di mia (attività inibitoria melanoma) per identificare, prevenire e curare la vitiligine |
-
1994
- 1994-07-19 EP EP94925364A patent/EP0710248B1/de not_active Expired - Lifetime
- 1994-07-19 AT AT94925364T patent/ATE185152T1/de active
- 1994-07-19 ZA ZA945278A patent/ZA945278B/xx unknown
- 1994-07-19 US US08/578,649 patent/US5770366A/en not_active Expired - Lifetime
- 1994-07-19 EP EP99101554A patent/EP0947583A3/de not_active Withdrawn
- 1994-07-19 CN CN94192822A patent/CN1056617C/zh not_active Expired - Lifetime
- 1994-07-19 WO PCT/EP1994/002369 patent/WO1995003328A2/de not_active Ceased
- 1994-07-19 DK DK94925364T patent/DK0710248T3/da active
- 1994-07-19 ES ES94925364T patent/ES2139751T3/es not_active Expired - Lifetime
- 1994-07-19 DE DE4425481A patent/DE4425481A1/de not_active Withdrawn
- 1994-07-19 CA CA002167693A patent/CA2167693C/en not_active Expired - Lifetime
- 1994-07-19 JP JP50493195A patent/JP3435163B2/ja not_active Expired - Lifetime
- 1994-07-19 AU AU75312/94A patent/AU7531294A/en not_active Abandoned
- 1994-07-19 DE DE59408791T patent/DE59408791D1/de not_active Expired - Lifetime
- 1994-07-20 IL IL11038594A patent/IL110385A/xx not_active IP Right Cessation
- 1994-07-20 IL IL154248A patent/IL154248A/en not_active IP Right Cessation
-
1999
- 1999-12-22 GR GR990403299T patent/GR3032212T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0947583A2 (de) | 1999-10-06 |
| IL110385A0 (en) | 1994-10-21 |
| EP0710248A1 (de) | 1996-05-08 |
| CN1056617C (zh) | 2000-09-20 |
| EP0710248B1 (de) | 1999-09-29 |
| AU7531294A (en) | 1995-02-20 |
| US5770366A (en) | 1998-06-23 |
| DK0710248T3 (da) | 2000-04-10 |
| CA2167693C (en) | 2007-01-30 |
| IL154248A (en) | 2008-08-07 |
| ZA945278B (en) | 1996-01-19 |
| ATE185152T1 (de) | 1999-10-15 |
| EP0947583A3 (de) | 2000-05-03 |
| CN1133049A (zh) | 1996-10-09 |
| GR3032212T3 (en) | 2000-04-27 |
| JP3435163B2 (ja) | 2003-08-11 |
| CA2167693A1 (en) | 1995-02-02 |
| WO1995003328A2 (de) | 1995-02-02 |
| DE4425481A1 (de) | 1995-03-02 |
| ES2139751T3 (es) | 2000-02-16 |
| DE59408791D1 (de) | 1999-11-04 |
| JPH09500531A (ja) | 1997-01-21 |
| WO1995003328A3 (de) | 1995-03-16 |
| IL154248A0 (en) | 2003-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3032212T3 (en) | Melanoma-inhibiting protein | |
| ZA200005843B (en) | New nucleotide sequences which code for the pck gene. | |
| CA2166685A1 (en) | An enzyme with protease activity | |
| GR3019043T3 (en) | Protein having cytokin type activity, recombinant DNA coding for this protein, transformed cells and microorganisms. | |
| AU2795292A (en) | Synthetic dna sequence having enhanced insecticidal activity in maize | |
| AU7587696A (en) | Differentiation-suppressive polypeptide | |
| SG49845A1 (en) | Novel pesticidal proteins strains | |
| EP0962531A3 (en) | Interferon-gamma production inducing isolated polypeptide fragment and an isolated DNA fragment encoding said polypeptide | |
| AU2001271786A1 (en) | Interferon-like protein zcyto21 | |
| AU2875492A (en) | Recombinant core-streptavidin | |
| CA2102702A1 (en) | Vitamin K-Dependent Carboxylase | |
| CA2188279A1 (en) | Interleukin-15 receptors | |
| CA2252493A1 (en) | .beta.-galactoside - .alpha. 2,6-sialyltransferase gene | |
| NZ331829A (en) | Clostridium perfringens vaccines | |
| EP0479071A3 (en) | Polypeptide | |
| AU2898995A (en) | Dna coding for phosphoenolpyruvate carboxykinase, recombinant vector containing the same, and transgenic plant | |
| AU7949991A (en) | Cloned n-methylhydantoinase | |
| AU6659896A (en) | Protein with plant protecting properties | |
| IL116019A0 (en) | Nucleic acids coding for penicillin v amidohydrolase expression vectors and host cells containing the same and methods for the production thereof | |
| CA2301902A1 (en) | Novel extracellular serine protease | |
| CA2155332A1 (en) | Polypeptide having cold-stable pyruvate, orthophosphate dikinase activity, dna encoding the same and recombinant vector and transformed plants containing the dna | |
| CA2448347A1 (en) | Novel human hydroxylases and polynucleotides encoding the same | |
| AU5637298A (en) | Novel cytochrome P450 gene | |
| EP0477791A3 (en) | Polypeptide | |
| ATE398681T1 (de) | Nukleotidsequenzen die für das mene-gen kodieren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| HP | Change in proprietorship |
Owner name: SCIL TECHNOLOGY GMBH. Free format text: FORMER OWNER:ROCHE DIAGNOSTICS GMBH |
|
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |